Ultragenyx Pharmaceutical
RARE
#5299
Rank
NZ$2.96 B
Marketcap
NZ$29.11
Share price
-1.17%
Change (1 day)
-49.17%
Change (1 year)

Ultragenyx Pharmaceutical (RARE) Fails to deliver data

Key failure to deliver metrics for Ultragenyx Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ultragenyx Pharmaceutical (RARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ultragenyx Pharmaceutical (RARE) - since 2014

Volume in USD (price x number of shares), data since 2014

Ultragenyx Pharmaceutical (RARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$3.56 M-75.4%
2023NZ$14.48 M344.12%
2022NZ$3.26 M-64.77%
2021NZ$9.26 M-20.49%
2020NZ$11.64 M-3.02%
2019NZ$12.01 M-75.7%
2018NZ$49.42 M-12.01%
2017NZ$56.16 M-14.47%
2016NZ$65.66 M-56.5%
2015NZ$0.15 B326.02%
2014NZ$35.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Lexicon Pharmaceuticals
LXRX
NZ$1.06 MNZ$3.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
N/ANZ$21.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
N/ANZ$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$9.39 MNZ$23.37 M๐Ÿ‡บ๐Ÿ‡ธ USA